Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 268

1.

Changing Team Member Perceptions by Implementing TeamSTEPPS in an Emergency Department.

Obenrader C, Broome ME, Yap TL, Jamison F.

J Emerg Nurs. 2018 Oct 12. pii: S0099-1767(17)30223-4. doi: 10.1016/j.jen.2018.08.006. [Epub ahead of print]

PMID:
30322675
2.

Target-based therapeutic matching of phase I trials in patients with metastatic breast cancer in a tertiary referral centre.

O'Carrigan B, Lim JSJ, Jalil A, Harris SJ, Papadatos-Pastos D, Banerji U, Lopez J, de Bono JS, Yap TA.

Br J Cancer. 2018 Oct 15. doi: 10.1038/s41416-018-0290-8. [Epub ahead of print]

PMID:
30318518
3.

Nonclonal Chromosomal Aberrations in Childhood Leukemia Survivors.

Chin TF, Ibrahim K, Thirunavakarasu T, Azanan MS, Oh L, Lum SH, Yap TY, Ariffin H.

Fetal Pediatr Pathol. 2018 Oct 1:1-11. doi: 10.1080/15513815.2018.1492054. [Epub ahead of print]

PMID:
30273079
4.

A phase I study to assess afatinib in combination with carboplatin or with carboplatin plus paclitaxel in patients with advanced solid tumors.

O'Brien MER, Sarker D, Bhosle J, Thillai K, Yap TA, Uttenreuther-Fischer M, Pemberton K, Jin X, Wiebe S, de Bono J, Spicer J.

Cancer Chemother Pharmacol. 2018 Nov;82(5):757-766. doi: 10.1007/s00280-018-3661-1. Epub 2018 Aug 7.

PMID:
30088048
5.

Targeting gamma secretase: has progress moved up a Notch?

Ileana Dumbrava EE, Mills GB, Yap TA.

Ann Oncol. 2018 Sep 1;29(9):1889-1891. doi: 10.1093/annonc/mdy307. No abstract available.

PMID:
30084907
6.

Fertility managment in testicular cancer: the need to establish a standardized and evidence-based patient-centric pathway.

Moody JA, Ahmed K, Yap T, Minhas S, Shabbir M.

BJU Int. 2018 Jun 19. doi: 10.1111/bju.14455. [Epub ahead of print] Review.

PMID:
29920910
7.

Real-Time Imaging of Retinal Ganglion Cell Apoptosis.

Yap TE, Donna P, Almonte MT, Cordeiro MF.

Cells. 2018 Jun 15;7(6). pii: E60. doi: 10.3390/cells7060060. Review.

8.

Combination drug development in BRAF mutant colorectal cancer.

Lam M, Pant S, Yap TA.

Oncoscience. 2018 Apr 29;5(3-4):51-53. doi: 10.18632/oncoscience.399. eCollection 2018 Mar. No abstract available.

9.

Challenges with biomarkers in cancer drug discovery and development.

Ileana Dumbrava E, Meric-Bernstam F, Yap TA.

Expert Opin Drug Discov. 2018 Aug;13(8):685-690. doi: 10.1080/17460441.2018.1479740. Epub 2018 May 24. No abstract available.

PMID:
29792354
10.

Predicting the Presence of Oral Squamous Cell Carcinoma Using Commonly Dysregulated MicroRNA in Oral Swirls.

Yap T, Koo K, Cheng L, Vella LJ, Hill AF, Reynolds E, Nastri A, Cirillo N, Seers C, McCullough M.

Cancer Prev Res (Phila). 2018 Aug;11(8):491-502. doi: 10.1158/1940-6207.CAPR-17-0409. Epub 2018 May 15.

PMID:
29764807
11.

Reporting on longitudinal live birth rates and cumulative delivery rates are more realistic outcome measures than sperm retrieval rates in couples undergoing mTESE-ICSI.

Almekaty K, Abomelha S, Thum Y, Nicopoullos J, Bracewell-Milnes T, Yap T, Minhas S.

Hum Fertil (Camb). 2018 May 10:1-6. doi: 10.1080/14647273.2018.1472396. [Epub ahead of print]

PMID:
29745280
12.

Untying the gordion knot of targeting MET in cancer.

Raghav K, Bailey AM, Loree JM, Kopetz S, Holla V, Yap TA, Wang F, Chen K, Salgia R, Hong D.

Cancer Treat Rev. 2018 May;66:95-103. doi: 10.1016/j.ctrv.2018.04.008. Epub 2018 Apr 26. Review.

PMID:
29730462
13.

Annexins in Glaucoma.

Yap TE, Davis BM, Guo L, Normando EM, Cordeiro MF.

Int J Mol Sci. 2018 Apr 17;19(4). pii: E1218. doi: 10.3390/ijms19041218. Review.

14.

Fertility preservation in testicular cancer - predictors of spermatogenesis.

Moody JA, Ahmed K, Horsfield C, Pedersen MRV, Yap T, Shabbir M.

BJU Int. 2018 Aug;122(2):236-242. doi: 10.1111/bju.14214. Epub 2018 Apr 17.

PMID:
29667332
15.

Introduced bullfrog facilitates pathogen invasion in the western United States.

Yap TA, Koo MS, Ambrose RF, Vredenburg VT.

PLoS One. 2018 Apr 16;13(4):e0188384. doi: 10.1371/journal.pone.0188384. eCollection 2018.

16.

A study into the association between local recurrence rates and surgical resection margins in organ-sparing surgery for penile squamous cell cancer.

Sri D, Sujenthiran A, Lam W, Minter J, Tinwell BE, Corbishley CM, Yap T, Sharma DM, Ayres BE, Watkin NW.

BJU Int. 2018 Oct;122(4):576-582. doi: 10.1111/bju.14222. Epub 2018 Apr 27.

PMID:
29604228
17.

BRD4 Inhibition Is Synthetic Lethal with PARP Inhibitors through the Induction of Homologous Recombination Deficiency.

Sun C, Yin J, Fang Y, Chen J, Jeong KJ, Chen X, Vellano CP, Ju Z, Zhao W, Zhang D, Lu Y, Meric-Bernstam F, Yap TA, Hattersley M, O'Connor MJ, Chen H, Fawell S, Lin SY, Peng G, Mills GB.

Cancer Cell. 2018 Mar 12;33(3):401-416.e8. doi: 10.1016/j.ccell.2018.01.019.

PMID:
29533782
18.

Targeting the PI3K pathway in cancer: are we making headway?

Janku F, Yap TA, Meric-Bernstam F.

Nat Rev Clin Oncol. 2018 May;15(5):273-291. doi: 10.1038/nrclinonc.2018.28. Epub 2018 Mar 6. Review.

PMID:
29508857
19.

TEAM-UP for quality: a cluster randomized controlled trial protocol focused on preventing pressure ulcers through repositioning frequency and precipitating factors.

Yap TL, Kennerly SM, Horn SD, Bergstrom N, Datta S, Colon-Emeric C.

BMC Geriatr. 2018 Feb 20;18(1):54. doi: 10.1186/s12877-018-0744-0.

20.

Precision Oncology Decision Support: Current Approaches and Strategies for the Future.

Kurnit KC, Dumbrava EEI, Litzenburger B, Khotskaya YB, Johnson AM, Yap TA, Rodon J, Zeng J, Shufean MA, Bailey AM, Sánchez NS, Holla V, Mendelsohn J, Shaw KM, Bernstam EV, Mills GB, Meric-Bernstam F.

Clin Cancer Res. 2018 Jun 15;24(12):2719-2731. doi: 10.1158/1078-0432.CCR-17-2494. Epub 2018 Feb 2. Review.

PMID:
29420224
21.

Efficacy and Toxic Effects of Cancer Immunotherapy Combinations-A Double-edged Sword.

Tang C, Jiang W, Yap TA.

JAMA Oncol. 2018 Aug 1;4(8):1116-1117. doi: 10.1001/jamaoncol.2017.4606. No abstract available.

PMID:
29327039
22.

A comparison of time taken to return to baseline erectile function following focal and whole gland ablative therapies for localized prostate cancer: A systematic review.

Faure Walker NA, Norris JM, Shah TT, Yap T, Cathcart P, Moore CM, Ahmed HU, Emberton M, Minhas S.

Urol Oncol. 2018 Feb;36(2):67-76. doi: 10.1016/j.urolonc.2017.12.002. Epub 2017 Dec 23. Review.

PMID:
29277585
23.

High frequency of radiological differential responses with poly(ADP-Ribose) polymerase (PARP) inhibitor therapy.

Perez-Lopez R, Roda D, Jimenez B, Brown J, Mateo J, Carreira S, Lopez J, Banerji U, Molife LR, Koh DM, Kaye SB, de Bono JS, Tunariu N, Yap TA.

Oncotarget. 2017 Nov 6;8(61):104430-104443. doi: 10.18632/oncotarget.22303. eCollection 2017 Nov 28.

24.

Precision oncology: East meets West.

Subbiah V, Rodon J, Yap TA.

Int J Cancer. 2018 May 1;142(9):1734-1737. doi: 10.1002/ijc.31218. Epub 2018 Jan 4. No abstract available.

PMID:
29243227
25.

Precision Medicine: Progress, Pitfalls, and Promises.

Pilié PG, LoRusso PM, Yap TA.

Mol Cancer Ther. 2017 Dec;16(12):2641-2644. doi: 10.1158/1535-7163.MCT-17-0904. No abstract available.

PMID:
29203693
26.

The Effect of Food or Omeprazole on the Pharmacokinetics of Osimertinib in Patients With Non-Small-Cell Lung Cancer and in Healthy Volunteers.

Vishwanathan K, Dickinson PA, Bui K, Cassier PA, Greystoke A, Lisbon E, Moreno V, So K, Thomas K, Weilert D, Yap TA, Plummer R.

J Clin Pharmacol. 2018 Apr;58(4):474-484. doi: 10.1002/jcph.1035. Epub 2017 Nov 26.

PMID:
29178442
27.

Resident Vignettes for Assessing Care Quality in Nursing Homes.

Colón-Emeric CS, Corazzini KN, McConnell ES, Pan W, Toles MP, Hall R, Batchelor-Murphy M, Yap TL, Anderson AL, Burd A, Amarasekara S, Anderson RA.

J Am Med Dir Assoc. 2018 May;19(5):405-410. doi: 10.1016/j.jamda.2017.10.018. Epub 2017 Nov 22.

PMID:
29174560
28.

Batrachochytrium salamandrivorans and the Risk of a Second Amphibian Pandemic.

Yap TA, Nguyen NT, Serr M, Shepack A, Vredenburg VT.

Ecohealth. 2017 Dec;14(4):851-864. doi: 10.1007/s10393-017-1278-1. Epub 2017 Nov 16. Review.

PMID:
29147975
29.

A Population of Heterogeneous Breast Cancer Patient-Derived Xenografts Demonstrate Broad Activity of PARP Inhibitor in BRCA1/2 Wild-Type Tumors.

Evans KW, Yuca E, Akcakanat A, Scott SM, Arango NP, Zheng X, Chen K, Tapia C, Tarco E, Eterovic AK, Black DM, Litton JK, Yap TA, Tripathy D, Mills GB, Meric-Bernstam F.

Clin Cancer Res. 2017 Nov 1;23(21):6468-6477. doi: 10.1158/1078-0432.CCR-17-0615.

PMID:
29093017
30.

Myocardial Injury Is Distinguished from Stable Angina by a Set of Candidate Plasma Biomarkers Identified Using iTRAQ/MRM-Based Approach.

Cheow ESH, Cheng WC, Yap T, Dutta B, Lee CN, Kleijn DPV, Sorokin V, Sze SK.

J Proteome Res. 2018 Jan 5;17(1):499-515. doi: 10.1021/acs.jproteome.7b00651. Epub 2017 Nov 7.

PMID:
29068691
31.

Development of Molecularly Driven Targeted Combination Strategies.

Yap TA, Rodon J.

Oncologist. 2017 Dec;22(12):1421-1423. doi: 10.1634/theoncologist.2017-0402. Epub 2017 Oct 16. No abstract available.

32.

A study of PD-L1 expression in KRAS mutant non-small cell lung cancer cell lines exposed to relevant targeted treatments.

Minchom A, Thavasu P, Ahmad Z, Stewart A, Georgiou A, O'Brien MER, Popat S, Bhosle J, Yap TA, de Bono J, Banerji U.

PLoS One. 2017 Oct 5;12(10):e0186106. doi: 10.1371/journal.pone.0186106. eCollection 2017.

33.

Effect of Promoting High-Quality Staff Interactions on Fall Prevention in Nursing Homes: A Cluster-Randomized Trial.

Colón-Emeric CS, Corazzini K, McConnell ES, Pan W, Toles M, Hall R, Cary MP Jr, Batchelor-Murphy M, Yap T, Anderson AL, Burd A, Amarasekara S, Anderson RA.

JAMA Intern Med. 2017 Nov 1;177(11):1634-1641. doi: 10.1001/jamainternmed.2017.5073.

PMID:
28973516
34.

Neuronal defects an etiological factor in congenital pelviureteric junction obstruction?

How GY, Chang KTE, Jacobsen AS, Yap TL, Ong CCP, Low Y, Allen JC, Kuick CH, Lim MZL, Laksmi NK.

J Pediatr Urol. 2018 Feb;14(1):51.e1-51.e7. doi: 10.1016/j.jpurol.2017.07.014. Epub 2017 Sep 1.

PMID:
28927720
35.

Anorectal malformation & Hirschsprung's disease: A cross-sectional comparison of quality of life and bowel function to healthy controls.

Nah SA, Ong CCP, Saffari SE, Ong LY, Yap TL, Low Y, Jacobsen AS.

J Pediatr Surg. 2018 Aug;53(8):1550-1554. doi: 10.1016/j.jpedsurg.2017.08.018. Epub 2017 Aug 25.

PMID:
28916047
36.

Phase I clinical trials in patients with advanced non-small cell lung cancer treated within a Drug Development Unit: What have we learnt?

Capelan M, Roda D, Geuna E, Rihawi K, Bodla S, Kaye SB, Bhosle J, Banerji U, O'Brien M, de Bono JS, Popat S, Yap TA.

Lung Cancer. 2017 Sep;111:6-11. doi: 10.1016/j.lungcan.2017.06.005. Epub 2017 Jun 15.

37.

Novel insights into mesothelioma biology and implications for therapy.

Yap TA, Aerts JG, Popat S, Fennell DA.

Nat Rev Cancer. 2017 Jul 25;17(8):475-488. doi: 10.1038/nrc.2017.42. Review.

PMID:
28740119
38.

Challenges of Treating Childhood Medulloblastoma in a Country With Limited Resources: 20 Years of Experience at a Single Tertiary Center in Malaysia.

Rajagopal R, Abd-Ghafar S, Ganesan D, Bustam Mainudin AZ, Wong KT, Ramli N, Jawin V, Lum SH, Yap TY, Bouffet E, Qaddoumi I, Krishnan S, Ariffin H, Abdullah WA.

J Glob Oncol. 2016 Jun 15;3(2):143-156. doi: 10.1200/JGO.2015.002659. eCollection 2017 Apr.

39.

Targeting ATR in cancer medicine.

Sundar R, Brown J, Ingles Russo A, Yap TA.

Curr Probl Cancer. 2017 Jul - Aug;41(4):302-315. doi: 10.1016/j.currproblcancer.2017.05.002. Epub 2017 May 17. Review.

PMID:
28662958
40.

Young adult survivors of childhood acute lymphoblastic leukemia show evidence of chronic inflammation and cellular aging.

Ariffin H, Azanan MS, Abd Ghafar SS, Oh L, Lau KH, Thirunavakarasu T, Sedan A, Ibrahim K, Chan A, Chin TF, Liew FF, Jeyamogan S, Rosli ES, Baharudin R, Yap TY, Skinner R, Lum SH, Hainaut P.

Cancer. 2017 Nov 1;123(21):4207-4214. doi: 10.1002/cncr.30857. Epub 2017 Jun 27.

PMID:
28654149
41.

Challenges in GC-MS analysis: Case studies on phenibut and ethylphenidate.

Lee HZS, Ong MC, Lim JLW, Yap TWA.

Forensic Sci Int. 2017 Aug;277:166-178. doi: 10.1016/j.forsciint.2017.06.002. Epub 2017 Jun 9.

PMID:
28651175
42.

Targeting BRAF-Mutant Colorectal Cancer: Progress in Combination Strategies.

Sundar R, Hong DS, Kopetz S, Yap TA.

Cancer Discov. 2017 Jun;7(6):558-560. doi: 10.1158/2159-8290.CD-17-0087.

43.

Baseline clinical predictors of antitumor response to the PARP inhibitor olaparib in germline BRCA1/2 mutated patients with advanced ovarian cancer.

Rafii S, Gourley C, Kumar R, Geuna E, Ern Ang J, Rye T, Chen LM, Shapira-Frommer R, Friedlander M, Matulonis U, De Greve J, Oza AM, Banerjee S, Molife LR, Gore ME, Kaye SB, Yap TA.

Oncotarget. 2017 Jul 18;8(29):47154-47160. doi: 10.18632/oncotarget.17005.

44.

Imprecision in the Era of Precision Medicine in Non-Small Cell Lung Cancer.

Sundar R, Chénard-Poirier M, Collins DC, Yap TA.

Front Med (Lausanne). 2017 Apr 10;4:39. doi: 10.3389/fmed.2017.00039. eCollection 2017. Review.

45.

Global Fecal and Plasma Metabolic Dynamics Related to Helicobacter pylori Eradication.

Yap TW, Leow AH, Azmi AN, Callahan DL, Perez-Perez GI, Loke MF, Goh KL, Vadivelu J.

Front Microbiol. 2017 Mar 30;8:536. doi: 10.3389/fmicb.2017.00536. eCollection 2017.

46.

Circulating tumor DNA-From bench to bedside.

Lim JSJ, Janku F, Yap TA.

Curr Probl Cancer. 2017 May - Jun;41(3):212-221. doi: 10.1016/j.currproblcancer.2017.02.005. Epub 2017 Mar 1.

PMID:
28416241
47.

Screening Commercial Vehicle Drivers for Obstructive Sleep Apnea: Tools, Barriers, and Recommendations.

Evans KA, Yap T, Turner B.

Workplace Health Saf. 2017 Oct;65(10):487-492. doi: 10.1177/2165079917692597. Epub 2017 Apr 17.

PMID:
28414584
48.

Advances in the Development of Molecularly Targeted Agents in Non-Small-Cell Lung Cancer.

Dolly SO, Collins DC, Sundar R, Popat S, Yap TA.

Drugs. 2017 May;77(8):813-827. doi: 10.1007/s40265-017-0732-2. Review.

PMID:
28378229
49.

Precision medicine in oncology.

Takebe N, Yap TA.

Curr Probl Cancer. 2017 May - Jun;41(3):163-165. doi: 10.1016/j.currproblcancer.2017.01.001. Epub 2017 Jan 24. No abstract available.

PMID:
28372822
50.

Extracranial Soft-Tissue Tumors: Repeatability of Apparent Diffusion Coefficient Estimates from Diffusion-weighted MR Imaging.

Winfield JM, Tunariu N, Rata M, Miyazaki K, Jerome NP, Germuska M, Blackledge MD, Collins DJ, de Bono JS, Yap TA, deSouza NM, Doran SJ, Koh DM, Leach MO, Messiou C, Orton MR.

Radiology. 2017 Jul;284(1):88-99. doi: 10.1148/radiol.2017161965. Epub 2017 Mar 16.

Supplemental Content

Support Center